Karyn S Mallya

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM TSPO is a neuroinflammatory biomarker and emerging therapeutic target in psychiatric disorders. We evaluated whether TSPO polymorphisms contribute to interindividual variability in schizophrenia, antipsychotic efficacy and antipsychotic-induced weight gain. PATIENTS & METHODS We analyzed TSPO polymorphisms in 670 schizophrenia cases and 775 healthy(More)
  • 1